NovelStem International Corp. (NSTM)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.57 Million USD | 1139.24% |
| 2022 | 288.45 Thousand USD | 188.45% |
| 2021 | 100 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2013 | 34.25 Thousand USD | 86.07% |
| 2012 | 18.4 Thousand USD | -51.6% |
| 2011 | 38.03 Thousand USD | -62.2% |
| 2010 | 100.61 Thousand USD | -57.86% |
| 2009 | 238.77 Thousand USD | -50.96% |
| 2008 | 486.88 Thousand USD | -10.74% |
| 2007 | 545.49 Thousand USD | -91.58% |
| 2006 | 6.48 Million USD | -0.38% |
| 2005 | 6.5 Million USD | 529.45% |
| 2004 | 1.03 Million USD | -79.46% |
| 2003 | 5.03 Million USD | 507.5% |
| 2002 | 828.62 Thousand USD | -56.8% |
| 2001 | 1.91 Million USD | -8.63% |
| 2000 | 2.09 Million USD | -40.03% |
| 1999 | 3.5 Million USD | 6.06% |
| 1998 | 3.3 Million USD | -8.33% |
| 1997 | 3.6 Million USD | 200.0% |
| 1996 | 1.2 Million USD | 200.0% |
| 1995 | 400 Thousand USD | -33.33% |
| 1994 | 600 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.11 Million USD | 5.08% |
| 2024 Q1 | 3.91 Million USD | 9.42% |
| 2023 Q1 | 357.52 Thousand USD | 23.95% |
| 2023 FY | 3.57 Million USD | 1139.24% |
| 2023 Q4 | 3.57 Million USD | 9.55% |
| 2023 Q3 | 3.26 Million USD | 19.81% |
| 2023 Q2 | 2.72 Million USD | 661.75% |
| 2022 Q3 | 168.2 Thousand USD | 68.21% |
| 2022 Q4 | 288.45 Thousand USD | 71.48% |
| 2022 FY | 288.45 Thousand USD | 188.45% |
| 2022 Q1 | - USD | -100.0% |
| 2022 Q2 | 100 Thousand USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 100 Thousand USD | 0.0% |
| 2021 Q4 | 100 Thousand USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2013 Q3 | 39.95 Thousand USD | -12.12% |
| 2013 FY | 34.25 Thousand USD | 86.07% |
| 2013 Q1 | 50.8 Thousand USD | 176.01% |
| 2013 Q2 | 45.46 Thousand USD | -10.51% |
| 2013 Q4 | 34.25 Thousand USD | -14.28% |
| 2012 Q2 | 28.8 Thousand USD | -14.74% |
| 2012 Q3 | 23.68 Thousand USD | -17.78% |
| 2012 Q4 | 18.4 Thousand USD | -22.29% |
| 2012 FY | 18.4 Thousand USD | -51.6% |
| 2012 Q1 | 33.78 Thousand USD | -11.16% |
| 2011 Q3 | 44.48 Thousand USD | -28.51% |
| 2011 FY | 38.03 Thousand USD | -62.2% |
| 2011 Q1 | 84.96 Thousand USD | -15.55% |
| 2011 Q4 | 38.03 Thousand USD | -14.51% |
| 2011 Q2 | 62.22 Thousand USD | -26.76% |
| 2010 Q2 | 128.28 Thousand USD | -30.95% |
| 2010 Q4 | 100.61 Thousand USD | -0.38% |
| 2010 Q3 | 100.98 Thousand USD | -21.28% |
| 2010 Q1 | 185.78 Thousand USD | -22.19% |
| 2010 FY | 100.61 Thousand USD | -57.86% |
| 2009 Q4 | 238.77 Thousand USD | -17.35% |
| 2009 Q1 | 426.09 Thousand USD | -12.49% |
| 2009 FY | 238.77 Thousand USD | -50.96% |
| 2009 Q2 | 340.49 Thousand USD | -20.09% |
| 2009 Q3 | 288.88 Thousand USD | -15.16% |
| 2008 Q1 | 513.06 Thousand USD | -5.94% |
| 2008 FY | 486.88 Thousand USD | -10.74% |
| 2008 Q3 | 432.74 Thousand USD | -17.44% |
| 2008 Q2 | 524.13 Thousand USD | 2.16% |
| 2008 Q4 | 486.88 Thousand USD | 12.51% |
| 2007 Q1 | 6.86 Million USD | 5.94% |
| 2007 FY | 545.49 Thousand USD | -91.58% |
| 2007 Q4 | 545.49 Thousand USD | 15.42% |
| 2007 Q3 | 472.63 Thousand USD | 183.17% |
| 2007 Q2 | 166.9 Thousand USD | -97.57% |
| 2006 Q2 | 5.86 Million USD | -10.86% |
| 2006 Q4 | 6.48 Million USD | 5.54% |
| 2006 FY | 6.48 Million USD | -0.38% |
| 2006 Q3 | 6.14 Million USD | 4.81% |
| 2006 Q1 | 6.57 Million USD | 1.02% |
| 2005 Q4 | 6.5 Million USD | 507.33% |
| 2005 Q3 | 1.07 Million USD | -0.67% |
| 2005 Q2 | 1.07 Million USD | 0.03% |
| 2005 Q1 | 1.07 Million USD | 4.3% |
| 2005 FY | 6.5 Million USD | 529.45% |
| 2004 Q4 | 1.03 Million USD | -21.07% |
| 2004 FY | 1.03 Million USD | -79.46% |
| 2004 Q1 | 4.39 Million USD | -12.73% |
| 2004 Q2 | 4.81 Million USD | 9.53% |
| 2004 Q3 | 1.3 Million USD | -72.78% |
| 2003 Q2 | 4.64 Million USD | 12.35% |
| 2003 Q1 | 4.13 Million USD | 398.52% |
| 2003 FY | 5.03 Million USD | 507.5% |
| 2003 Q3 | 4.8 Million USD | 3.55% |
| 2003 Q4 | 5.03 Million USD | 4.75% |
| 2002 FY | 828.62 Thousand USD | -56.8% |
| 2002 Q3 | 982.48 Thousand USD | -74.53% |
| 2002 Q4 | 828.62 Thousand USD | -15.66% |
| 2002 Q2 | 3.85 Million USD | 218.78% |
| 2002 Q1 | 1.21 Million USD | -36.9% |
| 2001 Q1 | 2.15 Million USD | 2.48% |
| 2001 FY | 1.91 Million USD | -8.63% |
| 2001 Q2 | 1.31 Million USD | -38.89% |
| 2001 Q4 | 1.91 Million USD | 67.69% |
| 2001 Q3 | 1.14 Million USD | -13.0% |
| 2000 Q3 | 2.18 Million USD | -35.24% |
| 2000 Q4 | 2.09 Million USD | -3.9% |
| 2000 Q2 | 3.37 Million USD | 0.38% |
| 2000 Q1 | 3.36 Million USD | -4.0% |
| 2000 FY | 2.09 Million USD | -40.03% |
| 1999 Q4 | 3.5 Million USD | -10.26% |
| 1999 Q3 | 3.9 Million USD | -4.88% |
| 1999 FY | 3.5 Million USD | 6.06% |
| 1999 Q1 | 2.6 Million USD | -21.21% |
| 1999 Q2 | 4.1 Million USD | 57.69% |
| 1998 Q2 | 5.1 Million USD | 8.51% |
| 1998 Q3 | 4.4 Million USD | -13.73% |
| 1998 Q4 | 3.3 Million USD | -25.0% |
| 1998 Q1 | 4.7 Million USD | 30.56% |
| 1998 FY | 3.3 Million USD | -8.33% |
| 1997 Q3 | 1.6 Million USD | 60.0% |
| 1997 FY | 3.6 Million USD | 200.0% |
| 1997 Q4 | 3.6 Million USD | 125.0% |
| 1997 Q1 | 1.1 Million USD | -8.33% |
| 1997 Q2 | 1 Million USD | -9.09% |
| 1996 Q4 | 1.2 Million USD | -7.69% |
| 1996 FY | 1.2 Million USD | 200.0% |
| 1996 Q1 | 1.9 Million USD | 375.0% |
| 1996 Q2 | 1.3 Million USD | -31.58% |
| 1996 Q3 | 1.3 Million USD | 0.0% |
| 1995 FY | 400 Thousand USD | -33.33% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| 1994 Q4 | 600 Thousand USD | 500.0% |
| 1994 FY | 600 Thousand USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -59.58% |
| Arrayit Corporation | 1.07 Million USD | -231.544% |
| Atlantic International Corp. | 2.93 Million USD | -21.98% |
| Biocept, Inc. | 12.1 Million USD | 70.48% |
| Bioqual, Inc. | 3.58 Million USD | 0.345% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -4822.741% |
| DermTech, Inc. | 54.39 Million USD | 93.428% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.242% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 26.052% |
| iMD Companies, Inc. | 1.12 Million USD | -219.118% |
| IDenta Corp. | 789.14 Thousand USD | -352.971% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 68.061% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -8052.809% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 55.567% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 6.568% |
| Optigenex Inc. | 8.94 Million USD | 60.019% |
| PharmChem, Inc. | 77.35 Thousand USD | -4521.151% |
| Proteome Sciences plc | 17.15 Million USD | 79.161% |
| Response Genetics, Inc | 6.37 Million USD | 43.91% |
| Rennova Health, Inc. | 15.32 Million USD | 76.681% |
| RushNet, Inc. | 4.82 Million USD | 25.886% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -1626.576% |
| Stella Diagnostics Inc. | 6.2 Million USD | 42.352% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -98.58% |
| Todos Medical Ltd. | 38.34 Million USD | 90.679% |